Synaptogenix Inc (SNPX)
5.09
+0.33
(+6.93%)
USD |
NASDAQ |
May 03, 16:00
5.05
-0.04
(-0.79%)
After-Hours: 20:00
Synaptogenix Price: 5.09 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 4.84 | 5.38 | 4.720 | 5.09 | 163303.0 |
May 02, 2024 | 4.95 | 5.18 | 4.70 | 4.76 | 48696.00 |
May 01, 2024 | 4.70 | 4.99 | 4.37 | 4.83 | 53132.00 |
Apr 30, 2024 | 4.40 | 5.12 | 4.35 | 4.74 | 223025.0 |
Apr 29, 2024 | 4.49 | 4.58 | 4.41 | 4.452 | 21943.00 |
Apr 26, 2024 | 4.54 | 4.54 | 4.34 | 4.53 | 6926.00 |
Apr 25, 2024 | 4.45 | 4.60 | 4.413 | 4.413 | 3503.00 |
Apr 24, 2024 | 4.58 | 4.690 | 4.481 | 4.56 | 14442.00 |
Apr 23, 2024 | 4.39 | 4.79 | 4.381 | 4.57 | 40601.00 |
Apr 22, 2024 | 4.50 | 4.50 | 4.200 | 4.36 | 53626.00 |
Apr 19, 2024 | 4.64 | 4.71 | 4.252 | 4.33 | 29905.00 |
Apr 18, 2024 | 4.73 | 4.95 | 4.60 | 4.66 | 42233.00 |
Apr 17, 2024 | 4.69 | 4.959 | 4.375 | 4.80 | 121996.0 |
Apr 16, 2024 | 4.50 | 4.89 | 4.43 | 4.650 | 93298.00 |
Apr 15, 2024 | 4.72 | 4.80 | 4.42 | 4.42 | 95422.00 |
Apr 12, 2024 | 4.83 | 5.037 | 4.57 | 4.686 | 82800.00 |
Apr 11, 2024 | 4.71 | 5.07 | 4.61 | 4.825 | 72575.00 |
Apr 10, 2024 | 4.85 | 4.920 | 4.55 | 4.70 | 56627.00 |
Apr 09, 2024 | 5.78 | 5.95 | 4.772 | 4.94 | 249929.0 |
Apr 08, 2024 | 4.81 | 6.217 | 4.77 | 5.39 | 276929.0 |
Apr 05, 2024 | 4.15 | 5.35 | 4.15 | 5.000 | 137673.0 |
Apr 04, 2024 | 4.288 | 5.125 | 4.288 | 4.525 | 47616.00 |
Apr 03, 2024 | 4.635 | 4.682 | 3.865 | 4.50 | 69327.00 |
Apr 02, 2024 | 4.72 | 4.858 | 4.275 | 4.598 | 5702.00 |
Apr 01, 2024 | 4.825 | 4.85 | 4.50 | 4.592 | 4278.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.965
Minimum
Feb 13 2024
343.00
Maximum
Oct 12 2021
121.06
Average
150.00
Median
Dec 21 2020
Price Benchmarks
CEL-SCI Corp | 1.63 |
AIM ImmunoTech Inc | 0.4048 |
IGC Pharma Inc | 0.5112 |
NovaBay Pharmaceuticals Inc | 0.0949 |
Protalix BioTherapeutics Inc | 1.14 |
Price Related Metrics
Price to Book Value | 0.2269 |
Earnings Yield | -850.2% |
Market Cap | 5.524M |